PRELYMCA: PREvention of Post-mastectomy LYMphoceles by PAdding

Sponsor
Centre Hospitalier Universitaire, Amiens (Other)
Overall Status
Unknown status
CT.gov ID
NCT02894021
Collaborator
(none)
120
3
2
51
40
0.8

Study Details

Study Description

Brief Summary

Lymphoceles, or seromas, are the most frequent complication following mastectomy and are associated or not with axillary dissection occurring in 10 to 90% of cases. It is defined as the presence of a palpable post operative serous accumulation that is bothersome for the patient and requires a puncture and drainage or even several repeated punctures. The presence of seromas is therefore associated with discomfort and pain. Seromas could also be responsible for increased morbidity due to complications such as infection, suture separating, lymphedema, prolonged of hospital stay, or a delay in initiation of adjunct treatment (e.g. chemotherapy, radiotherapy). Some risk factors have been identified, such as obesity, increased post operative drainage of J1 to J3, and arterial hypertension.

Different measures have demonstrated the benefits of limiting axillary lymphoceles after dissection : placement of a drain, padding and delay in shoulder mobility.

Studies have shown that axillary padding decreases lymphocele development and shortens the length of hospital stay. Some studies based on padding of the mastectomy site also have shown a decrease in post operative seromas; however no study has been done on the usefulness of padding in the mastectomy site alone because they include both padding and a drain or padding of the axillary area.

The padding technique the investigators employ is performed at the donor site in breast reconstruction by latissimus dorsi muscle flap, demonstrating a reduction in the rate of seromas.

In this study, the classic technique will be compared to padding in the mastectomy site with short drainage (48h).

Condition or Disease Intervention/Treatment Phase
  • Procedure: classic closure
  • Procedure: padding
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
PREvention of Post-mastectomy LYMphoceles by PAdding. A Randomized Prospective Multicenter Study
Study Start Date :
May 1, 2013
Anticipated Primary Completion Date :
Aug 1, 2017
Anticipated Study Completion Date :
Aug 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: classic closure

mastectomy with classic closure in 2 steps, drainage by negative pressure aspiration

Procedure: classic closure
mastectomy with classic closure in 2 steps, drainage by negative pressure aspiration

Experimental: padding

areas of padding and stiching between subcutaneous tissue and pectoral muscle followed by closure in 2 steps, drainage by negative pressure aspiration for 48 h.

Procedure: padding
areas of padding and running sutures between subcutaneous tissue and pectoral muscle followed by closure in 2 steps, drainage by negative pressure aspiration for 48 h

Outcome Measures

Primary Outcome Measures

  1. postoperative lymphoceles [Day 15]

    presence or absence of postoperative lymphoceles

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥ 18 years

  • Female gender

  • Patients with infiltrating or in situ breast cancer

  • Indication of surgical treatment by mastectomy

  • Patient providing written informed consent

  • Patient with health insurance coverage

  • Ability to provide voluntary written informed consent

Exclusion Criteria:
  • Informed consent cannot be obtain

  • Pregnant or lactating women

  • Patients undergoing immediate breast reconstruction

  • Patients with cancer untreatable by mastectomy, non curative mastectomy: partial mastectomies, preventive mastectomies (BRCA genetic mutations)

  • Patients under legal protection or unable to come to a center

  • Patients unable to express voluntary consent

  • Patients receiving post operative anticoagulants or platelet antiaggregants

  • Patients requiring postoperative anticoagulants

  • Bilateral mastectomy

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Amiens Amiens France 80054
2 CH Compiègne Compiegne France 60321
3 CH Soissons Soissons France 02209

Sponsors and Collaborators

  • Centre Hospitalier Universitaire, Amiens

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire, Amiens
ClinicalTrials.gov Identifier:
NCT02894021
Other Study ID Numbers:
  • PI2013_843_0001
First Posted:
Sep 9, 2016
Last Update Posted:
Sep 9, 2016
Last Verified:
Sep 1, 2016
Keywords provided by Centre Hospitalier Universitaire, Amiens
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 9, 2016